Role of prostaglandin E2 in rat colon carcinoma

Hepato-Gastroenterology

Volumn 46, Issue 28, 1999, Pages 2347-2351

  Inaba, Akira ^a   Uchiyama, Tetsuji ^a   Oka, Masaaki ^a,b  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colon carcinogenesis; Indomethacin; n Methyl n nitrosoguanidine; n Methyl n nitrosourea; Prostaglandin E2

Indexed keywords

GUANIDINE DERIVATIVE; INDOMETACIN; METHYLNITROSOUREA; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON CARCINOGENESIS; COLON MUCOSA; COLON TUMOR; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ANIMALS; CARCINOGENS; COLON; COLONIC NEOPLASMS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; INDOMETHACIN; INTESTINAL MUCOSA; MALE; METHYLNITRONITROSOGUANIDINE; METHYLNITROSOUREA; RATS; RATS, INBRED STRAINS;

EID: 0032868530     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Pollard M, Luuckert PH: Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. Cancer Treat Rep 1980; 64:1323-1327.
2. Narisawa T, Sato M, Tani M, Kudo T, Takahashi T, Goto A: Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment, Cancer Res 1981; 41:1954-1957.
3. Metzer U, Meier J, Uhlschmid G, Weihe H: Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer. Dis Colon Rectum 1984; 27:366-369.
4. Crutchley DJ, Conanan LB, Maynard JR: Induction of plasminogen activator and prostaglandin biosynthesis in HeLa cells by 12-0-tetradecanoylphorbol-13-acetate. Cancer Res 1980; 40:849-852.
5. Furstenberger G, Marks F: Indomethacin inhibition biosynthesis of cell proliferation induced by the phorbolester TPA is reversed by prostaglandin E2 in vivo. Biochem Biophys Res Commun 1978; 84:1103-111.
6. Lupulescu A: Enhancement of carcinogenesis by prostaglandins in male albino Swiss mice. J Natl Cancer Inst 1978; 61:97-106.
7. Marx JL: Tumor promoters; carcinogenesis gets more complicated. Science 1978; 201:515-518.
8. Ohuchi K, Leviine L: Stimulation of prostaglandin synthesis by tumor-promoting thorbol-twelve, 13-diesters in canine kidney (MDCK) cells. J Biol Chem 1978; 253:4783-4790.
9. Verma AK, Ashendel CL, Boutwell RK: Inhibition by prostaglandin synthesis inhibitor of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-0-tetradecanoylphorbol-13-acetate. Cancer Res 1980; 40:308-315.
10. A, Tacca MD, Stanford IF, Zebro T: Prostaglandins from tumors of human large bowel. Br J Cancer 1977; 35:881-884.
11. Oka M, Inaba A, Uchiyama T, Hazama S, Shimoda K, Suzuki T: Prostaglandin E2 levels and lymphocyte subsets in portal venous drainage of colorectal cancers. Am J Surg 1994; 167:264-267.
12. Bennett A: Prostaglandin and Cancer. In: Marin SSM (Ed.). Practical applications of prostaglandins and their synthesis inhibitors. Lancaster, England: MTP Press Ltd, 1979; pp. 149-188.
13. Ferreria SH, Vane JR: New aspects of the mode of action or nonsteroid anti-inflammatory drugs. Ann Rev Pharmacol 1974; 14:57-73.
14. Jaffe BM: Prostaglandins and cancer: an update. Prostaglandins 1974; 6:453-460.
15. Lupulescu A: Effect of prostaglandins on protein, RNA, DNA, and collagen synthesis in experimental wounds. Prostaglandins 1975; 10:578-579.
16. Droller MJ, Perlmann P, Schneiden MU: Enhancement or natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor cells. Cell Immunol 1978; 39:154-164.
17. Droller MJ, Schneider MU, Perlmann P: A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell mediated cytotoxicity against tumor cells. Cell Immunol 1978; 39:165-177.
18. Schultz RM, Prvlidis NA, Stylos WA, Chirigos MA: Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series. Science 1978; 202:320-321.
19. Web DR, Osheroff PL: Antigen stimulation of prostaglandin synthesis and control of immune responses. Proc Natl Acad Sci USA 1975; 73:1300-1304.
20. Tanaka M, Nagasawa S, Koike M: Endogenous prostaglandin levers in DMH-induced rat colon cancer. Jpn J Gastroentelol 1985; 82:592-598. (In Japanese)
21. Narisawa T, Hermanek P, Habs M, Schmahl D: Reduction of carcinogenicity of n-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin. J Cancer Res Clin Oncol 1984; 108:239-242.
22. Raddy BS, Watanabe K: Effect of cholesterol metabolites and promoting effect of lithocholic acid in colon carcinogenesis in Germ-free and conventional F344 rats. Cancer Res 1979; 39:1521-1524.
23. Narisawa T, Takahashi M, Niwa M, Fukahara Y, Wakizawa A: Involvement of prostaglandin E2 in bile acid caused promotion of colon carcinogenesis and anti-promotion by the cyclooxygenase inhibitor indomethacin. Jpn J Cancer Res 1987; 78:791-798.
24. Jaffe BM, Behrman HR, Paarker CW: Radioimmunoassay measurement of Prostaglandin E, A, and F in human plasma. J Clin Invest 1973; 52:398-405.
25. Narizawa T, Hosaka S, Niwa M: Prostaglandin E2 counteracts the inhibition by indomethacin of rat colon ornithinedecarhoxylase induction by deoxycholic acid. Jpn J Cancer Res 1985; 76:338-344.
26. Fujiki H, Mori M, Nakayasu M, Terada M, Sugimura T: A possible naturally occurring tumor promote, teleocidin B, from Streptomyces. Biochem Biophys Res Commun 1979; 90:976-983.
27. Furihata C, Sato Y, Hosaka M, Matsushima T, Furukawa F, Takahashi M: NaCl induced ornithine decarboxlase and DNA synthesis in rat stomach mucosa. Biochem Biophys Res Commun 1984; 121:1027-1032.
28. Hosako S, Nagayama H, Hirono I, Haga M: Enhanced activity of ornithine decarboxylase of the ileum in rats by broken fern (Pteridium aquilium). Br Cancer 1988; 48:311-314.
29. Blot WJ, Lanier A, Fraumeni JF Jr, Bender TR: Cancer mortality among Alaskan natives, 1960-69. J Natl Cancer Inst 1975; 55:547-554.
30. Bartram HP, Gostner A, Scheppach W, Reddy BS, Rao CV, Dusel G, Richter F, Richter A, Kasper H: Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects. Gastroenterol 1993; 105:1317-1322.
31. Takahashi M, Fukutake M, Isoi T, Fukuda K, Sato H, Yazawa K, Sugimura T, Wakabayashi K: Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA). Carcinogenesis 1997; 18:1337-1342.